148 related articles for article (PubMed ID: 18196537)
1. Histopathological and immunohistochemical characterization of canine prostate cancer.
Lai CL; van den Ham R; van Leenders G; van der Lugt J; Mol JA; Teske E
Prostate; 2008 Apr; 68(5):477-88. PubMed ID: 18196537
[TBL] [Abstract][Full Text] [Related]
2. Comparative characterization of the canine normal prostate in intact and castrated animals.
Lai CL; van den Ham R; van Leenders G; van der Lugt J; Teske E
Prostate; 2008 Apr; 68(5):498-507. PubMed ID: 18213634
[TBL] [Abstract][Full Text] [Related]
3. Different Growth Patterns of Canine Prostatic Carcinoma Suggests Different Models of Tumor-Initiating Cells.
Akter SH; Lean FZ; Lu J; Grieco V; Palmieri C
Vet Pathol; 2015 Nov; 52(6):1027-33. PubMed ID: 25755134
[TBL] [Abstract][Full Text] [Related]
4. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
5. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
6. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
[TBL] [Abstract][Full Text] [Related]
7. Verification of a canine PSMA (FolH1) antibody.
Wagner S; Maibaum D; Pich A; Nolte I; Murua Escobar H
Anticancer Res; 2015 Jan; 35(1):145-8. PubMed ID: 25550545
[TBL] [Abstract][Full Text] [Related]
8. A retrospective analysis of 111 canine prostatic samples: histopathological findings and classification.
Palmieri C; Lean FZ; Akter SH; Romussi S; Grieco V
Res Vet Sci; 2014 Dec; 97(3):568-73. PubMed ID: 25468798
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.
Kristiansen I; Stephan C; Jung K; Dietel M; Rieger A; Tolkach Y; Kristiansen G
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555048
[TBL] [Abstract][Full Text] [Related]
10. [Correlation study of expression levels of prostate-specific membrane antigen and prostate-specific antigen with Gleason score of prostate carcinoma].
Ren JQ; Chen ZQ; Zheng L; Chen Q; Li H; Zhu HG
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):735-8. PubMed ID: 15733392
[TBL] [Abstract][Full Text] [Related]
11. Cellular distribution and heterogeneity of Psa and Psma expression in normal, hyperplasia and human prostate cancer.
Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Horchani A; Oueslati R
Tunis Med; 2013 Jul; 91(7):458-63. PubMed ID: 24008878
[TBL] [Abstract][Full Text] [Related]
12. Hierarchical Cluster Analysis of Cytokeratins and Stem Cell Expression Profiles of Canine Cutaneous Epithelial Tumors.
Kok MK; Chambers JK; Ong SM; Nakayama H; Uchida K
Vet Pathol; 2018 Nov; 55(6):821-837. PubMed ID: 30071783
[TBL] [Abstract][Full Text] [Related]
13. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
Ben Jemaa A; Sallami S; Céraline J; Oueslati R
Cell Biol Int; 2013 May; 37(5):464-70. PubMed ID: 23418075
[TBL] [Abstract][Full Text] [Related]
14. Biochemical characterization of prostate-specific membrane antigen from canine prostate carcinoma cells.
Wu LY; Johnson JM; Simmons JK; Mendes DE; Geruntho JJ; Liu T; Dirksen WP; Rosol TJ; Davis WC; Berkman CE
Prostate; 2014 May; 74(5):451-7. PubMed ID: 24449207
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors.
Ramos-Vara JA; Miller MA; Boucher M; Roudabush A; Johnson GC
Vet Pathol; 2003 Jan; 40(1):55-62. PubMed ID: 12627713
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: implications for PSA surrogacy.
Kuroda K; Liu H; Kim S; Guo M; Navarro V; Bander NH
Prostate; 2009 Oct; 69(14):1579-85. PubMed ID: 19575420
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of prostate specific membrane antigen by canine hemangiosarcoma cells provides opportunity for the molecular detection of disease burdens within hemorrhagic body cavity effusions.
Dowling M; Samuelson J; Fadl-Alla B; Pondenis HC; Byrum M; Barger AM; Fan TM
PLoS One; 2019; 14(1):e0210297. PubMed ID: 30601866
[TBL] [Abstract][Full Text] [Related]
18. Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line.
Christiansen JJ; Rajasekaran SA; Moy P; Butch A; Goodglick L; Gu Z; Reiter RE; Bander NH; Rajasekaran AK
Prostate; 2003 Apr; 55(1):9-19. PubMed ID: 12640656
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of canine prostate-specific membrane antigen.
Schmidt S; Fracasso G; Colombatti M; Naim HY
Prostate; 2013 May; 73(6):642-50. PubMed ID: 23359458
[TBL] [Abstract][Full Text] [Related]
20. Histological and immunohistochemical investigation of canine prostate carcinoma with identification of common intraductal carcinoma component.
de Brot S; Lothion-Roy J; Grau-Roma L; White E; Guscetti F; Rubin MA; Mongan NP
Vet Comp Oncol; 2022 Mar; 20(1):38-49. PubMed ID: 33963663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
